PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.

Autores:

Tipo de recurso:

Fecha de publicación:

2016

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/25997

Acceso en línea:

https://doi.org/10.1016/j.jval.2016.03.1586
https://repository.urosario.edu.co/handle/10336/25997

Palabra clave:

Public Health and Health Services
Medical and Health Sciences
Applied Economics
Economics

Rights

License

Restringido (Acceso a grupos específicos)